March 1, 2021

FDA clearance for Masimo’s Rad-67 Pulse CO-Oximeter with Hemoglobin Spot-Check

Rad-67 Pulse CO-Oximeter with Spot-check Next Generation SpHb monitoring technology and the rainbow DCI-mini Reusable Sensor by Masimo has recently been granted FDA clearance. The device has been designed to facilitate quick noninvasive hemoglobin measurement. It also features Measure-through Motion and Low Perfusion SET pulse oximetry by Masimo. Thus it is a combination of the rainbow DCI-mini sensor; Rad-67 offers spot-check monitoring with Masimo’s Next Generation SpHb.

The device is powered by a rechargeable battery that will run for up to six hours, and can be used in a variety of settings, including ERs, pre/post op rooms, and doctors’ offices; which also makes it a portable device. It is controlled through a touch-screen interface. Thus the brightness can be set in accordance with the surrounding light levels. This makes it possible for clinicians to travel across rooms without having to adjust the screen for being too dim or too bright.

A vibration feedback when the sensor has been properly connected to its port, for instance is one of the many features incorporated in the Rad-67 Pulse CO-Oximeter with Spot-check Next Generation SpHb  which help ensure that all tests are performed without any hassles. Additionally, the operator is guided through the hemoglobin measurement process with a series of feedback screen.

The Rad-67 Pulse CO-Oximeter with Spot-check Next Generation SpHb can upload its data to the hospital’s electronic medical records as it is Wi-Fi enabled apart from having the option of saving and organizing all the measurements by the patient.


is a freelancer, a graduate of the University of Pennsylvania with a BA in English, he studied accounting at the Wharton School of Business, and currently lives in Staten Island has been covering business and technology for a variety of publications since 1989. He worked for Red Herring, Beyond Computing & Accounting Technolgy. He covers accounting, taxes, finance, government news & technology for the site Mail me

View all posts by THOMAS ROBBINS →

Leave a Reply

Your email address will not be published. Required fields are marked *